An MBA graduate of Harvard Business School, Raj Prabhakar is a seasoned business leader with more than two decades of industry experience in the biopharmaceutical sector, focusing the last decade on cell and gene therapy for rare diseases. He serves as Chief Business Officer and Senior Vice President at Rocket Pharmaceuticals. Raj Prabhakar has devoted his professional endeavors to funding and advancing pediatric rare diseases.
Rare Diseases and specifically pediatric rare diseases is growing concern in the United States. Many believe that public awareness of the risks of not genetically testing early enough is essential to finding cures early. Business leaders can actively spread genetic testing awareness and disease prevention when possible.
Engagement in research awareness and early detection can potentially be curative. Business leaders can incentivize workers to engage in better communication by spreading awareness of their health benefits both within their company and the general community. Business leaders can also create weekly walkathons, fundraising activities, and even genetic testing days at local hospitals . Since many of these diseases are genetic, testing family members and extended family can help spread awareness and benefits of genomic testing so it becomes more routine in the community.
Business leaders can engage employees to participate in programs with local hospitals. Prime beneficiaries include bone marrow cell banks, transplant centers and hospitals, and leading academic and research institutions.
In addition, businesses can sponsor screening tests at local hospitals by hosting free-coupon programs for certain diseases and even for organ transplants. Through these programs, employees and their families can get tested potentially for free when sponsored by the biopharmaceutical industry. These programs help promote early detection of diseases, which is pertinent to successful treatment.
Rare Diseases and specifically pediatric rare diseases is growing concern in the United States. Many believe that public awareness of the risks of not genetically testing early enough is essential to finding cures early. Business leaders can actively spread genetic testing awareness and disease prevention when possible.
Engagement in research awareness and early detection can potentially be curative. Business leaders can incentivize workers to engage in better communication by spreading awareness of their health benefits both within their company and the general community. Business leaders can also create weekly walkathons, fundraising activities, and even genetic testing days at local hospitals . Since many of these diseases are genetic, testing family members and extended family can help spread awareness and benefits of genomic testing so it becomes more routine in the community.
Business leaders can engage employees to participate in programs with local hospitals. Prime beneficiaries include bone marrow cell banks, transplant centers and hospitals, and leading academic and research institutions.
In addition, businesses can sponsor screening tests at local hospitals by hosting free-coupon programs for certain diseases and even for organ transplants. Through these programs, employees and their families can get tested potentially for free when sponsored by the biopharmaceutical industry. These programs help promote early detection of diseases, which is pertinent to successful treatment.